CAS: 138-39-6; Mafenide

该化合物是一种合成的磺酰胺抗生素,主要用于治疗烧伤和皮肤感染的热门应用,其特点是它能够通过干扰叶酸合成来抑制细菌生长,这对细菌扩散至关重要.Mafenide通常以白色为白,以脱白的晶状粉形式出现,在水中可溶解,具有略微苦味.它的化学结构特征是造成其抗微生物特性的磺酰胺组.该物质往往被配制成一种奶油或直接应用于受影响地区的溶液.该物质虽然对一系列克阳性和克阴性细菌有效,但可能会对某些病人造成局部刺激或过敏反应.人们特别注意到,它能够穿透食盐,因此对烧焦治疗很有价值.然而,其使用可能受到潜在副作用的限制,包括代谢酸性酸性中毒和超敏反应,需要在治疗期间进行仔细监测.

结构式图片

上下游产品

CAS号3119-02-6 对氰基苯磺酰胺 | CAS号2015-14-7 N-[4-(氨基磺酰基)苄基]乙酰胺 | CAS号28073-51-0 4-(乙酰氨基甲基)苯磺酰氯 | CAS号14289-29-3 4-sulfamoylbenz... | CAS号588-46-5 N-乙酰苄胺 | CAS号2522-79-4 amino-(4-sulfam... | CAS号142319-48-0 6-oxo-6-[(4-sul... | CAS号21266-66-0 Benzenesulfonam... | CAS号2393-24-0 4-benzylaminesu... | CAS号7518-98-1 4-[(1,3-dioxois... | CAS号824938-43-4 2-amino-N-[(4-s... | CAS号92093-09-9 2-methyl-N-[(4-... | CAS号4157-44-2 1-phenyl-3-[(4-...

合成工艺路线路线简述

    📜N-[4-(氨基磺酰基)苄基]乙酰胺置于sodium Hydroxide体系中,化学反应生成磺胺米隆
    参考文献:De726386
    标题:De726386

    海关参考信息

    专利信息


    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-2024197774-A1
    优先权日:2021-04-16
    标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
    发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
    权利人:UNIV TEXAS
    摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

    专利号:US-12221452-B2
    优先权日:2017-10-04
    标题:Synthesis of cantharidin
    发明人:DAVIDSON MATTHEW GENE; EKLOV BRIAN MATTHEW; WUTS PETER; LOERTSCHER BRAD MELVIN; SCHOW STEVEN R
    权利人:VERRICA PHARMACEUTICALS INC
    摘要:The invention provides synthetic methods for the preparation of cantharidin and analogs thereof. In one aspect, the invention provides an improved Diels-Alder cycloaddition to generate a key intermediate en route to cantharidin and analogs thereof. In certain embodiments, the new Diels-Alder reaction involves reacting Compound (2) in the presence of furan, and in the absence of acid or increased pressure, in an aprotic polar solvent with slight warming, to yield Compound (1) in favorable yield and exo-endo ratio. In another aspect, the invention also provides a new Diels-Alder reaction between compounds of Formula (III) and furan to yield compounds of Formula (IV), which can then be transformed into cantharidin or analogs thereof. In yet another aspect, the invention describes a new palladium-mediated carbonylation providing another key intermediate en route to cantharidin and analogs thereof. In addition to synthetic methods, present invention also provides compounds (i.e., intermediates) useful in the synthesis of cantharidin and analogs thereof. Compounds provided herein may have biological activity, and therefore may be used in the treatment of diseases or conditions (e.g., infectious diseases and skin conditions).

    专利号:US-2025129021-A1
    优先权日:2023-09-19
    标 题:Small molecule protein synthesis modulators
    发明人:GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
    权利人:INTERDICT BIO INC
    摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I), Formula (V)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

    专利号:US-7109377-B2
    优先权日:1996-10-16
    标 题:Synthesis of combinatorial libraries of compounds reminiscent of natural products
    发明人:SCHREIBER STUART L; SHAIR MATTHEW D; TAN DEREK S; FOLEY MICHAEL A; STOCKWELL BRENT R
    权利人:HARVARD COLLEGE
    摘要:The present invention provides complex compounds reminiscent of natural products and libraries thereof, as well as methods for their production. The inventive compounds and libraries of compounds are reminiscent of natural products in that they contain one or more stereocenters, and a high density and diversity of functionality. In general, the inventive libraries are synthesized from diversifiable scaffold structures, which are synthesized from readily available or easily synthesizable template structures. In certain embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from a shikimic acid based epoxyol template. In other embodiments, the inventive compounds and libraries are generated from diversifiable scaffolds synthesized from the pyridine-based template isonicotinamide. The present invention also provides a novel ortho-nitrobenzyl photolinker and a method for its synthesis. Furthermore, the present invention provides methods and kits for determining one or more biological activities of members of the inventive libraries. Additionally, the present invention provides pharmaceutical compositions containing one or more library members.

    专利号:US-8557979-B2
    优先权日:2004-06-10
    标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
    发明人:CHOI WOO-BAEG; KOWALIK EWA
    权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
    摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Rizzo JA, Martini AK, Pruskowski KA, Rowan MP, Niece KL, Akers KS. Thermal stability of mafenide and amphotericin B topical solution. Burns. 2018 Mar;44(2):475-480. doi: 10.1016/j.burns.2017.08.019. Epub 2017 Sep 19. 39(5):736-738. doi: 10.1093/jbcr/irx029. 38(1):e42-e47. doi: 10.1097/BCR.0000000000000425. 89(2):219-21. 38(4):e704-e707. doi: 10.1097/BCR.0000000000000455. 16(3):172-4. doi: 10.1017/s1049023x00025930. 38(1):39-54. doi: 10.1007/s10096-018-3393-5. Epub 2018 Oct 5. 1(6):434-60. doi: 10.2165/00003495-197101060-00002. 6(8):825-8.
    147:105303. doi: 10.1016/j.ejps.2020.105303. Epub 2020 Mar 12.

    合成参考文献


    参考文献:10.1136/bmj.c241
    摘要:Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ. 2010 Feb 15;340():c241.
    参考文献:10.1021/jm901855h
    摘要:Joseph P, Turtaut F, Ouahrani-Bettache S, Montero JL, Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Köhler S, Winum JY, Supuran CT. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. J Med Chem. 2010 Mar 11;53(5):2277–85. doi: 10.1021/jm901855h.
    参考文献:10.1016/j.bmc.2011.06.038
    摘要:Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Supuran CT. Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates. Bioorg Med Chem. 2011 Aug 15;19(16):5023–30. doi: 10.1016/j.bmc.2011.06.038.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知